Coronavirus is evolving but so are our antibodies

By Sarah L Caddy, Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge
Meng Wang, Cancer Research UK Clinician Scientist Fellow, University of Cambridge

The emergence of “variants of concern” has raised questions about our long-term immunity to the coronavirus. Will the antibodies we make after being infected with or vaccinated against the dominant lineage, called D614G, protect us against future viral variants?

To answer this question, scientists have been examining how our antibody responses to the coronavirus develop over time. Several studies have recently compared the difference between antibodies produced straight…

Read complete article

~	Hong Kong ranks low on global press freedom index as watchdog cites ‘unprecedented’ setbacks

~	Media coverage of campus protests tends to focus on the spectacle, rather than the substance

~	The good news is the government plans to cancel $3 billion in student debt. The bad news is indexation will still be high

~	Albanese government to wipe $3 billion in student debt, benefitting three million people

~	The Indigenous Peoples Camp that calls for rights every April in Brazil

~	Pillay: Israel is helped by ‘powerful States’ in violation of Palestinians’ rights

~	Debates on campus safety in response to Palestine solidarity activism show we need strategies to navigate discomfort

~	El Salvador: Constitution “à la carte” could deepen human rights crisis in coming years

~	Arrest Warrant Issued for Former Central African Republic President

~	With eyes on Gaza, violations against West Bank journalists multiply